What we do

We work with clinicians to make Fecal Microbiota Transplantation (FMT) easier, cheaper, safer and more widely available. We do so by providing hospitals with screened, filtered, and frozen material ready for clinical use. This service eliminates the time, staff, protocols, and facilities needed to screen and prepare material from new donors for each treatment. 

We also work to catalyze research into the microbiome and its role in human health. We provide tailored assistance in molecular characterization, computational analysis, clinical trial design, and regulatory support  for scientific and clinical research.  

Why we're here

We founded OpenBiome, a nonprofit 501(c)(3) organization, after watching a friend and family member suffer through 18 months of C. difficile and 7 rounds of vancomycin before finally receiving a successful, life-changing FMT. The remarkable efficacy of this treatment and the great lengths required to receive it convinced us that we needed to help expand access. After many discussions with local clinicians and the FDA, we launched OpenBiome in 2012 to make FMT safer and easier patients and doctors alike.